Aeluma CEO Klamkin terminates 10b5-1 share sale plan adopted in May 2026
Aeluma disclosed that CEO Jonathan Klamkin terminated a Rule 10b5-1 trading arrangement on October 21, 2026. The plan, adopted May 23, 2026, provided for the sale of up to 300,000 shares of common stock. The filing does not state whether any shares were sold under the plan.
Key points
- Plan adopted May 23, 2026 by Jonathan Klamkin, President, CEO and Chairman, allowing sale of up to 300,000 shares
- Klamkin terminated the 10b5-1 trading arrangement on October 21, 2026
- Plan was previously reported in the Annual Report on Form 10-K for the fiscal year ended June 30, 2026
The filing
Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 22, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.